AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pixium Vision

Report Publication Announcement Dec 11, 2019

1599_iss_2019-12-11_3effbaff-5a6e-4519-aa9a-62b412c3c9b6.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Pixium Vision's 2020 financial calendar

Paris, France. December 11, 2019 – 06.00 PM CET– Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces its 2020 financial calendar*:

  • 12th February, 2020 Full year 2019 financial results
  • 16 th April, 2020 – Cash position of March 31st, 2020
  • 28 th May, 2020 – Annual General Shareholders' Meeting
  • 23 rd July, 2020 – Half year 2020 financial results
  • 22 nd October, 2020 – Cash position of September 30th, 2020
  • * This financial calendar is for indicative purposes only. Pixium Vision may change the above dates if deemed necessary.

Contacts

Pixium Vision Didier Laurens Chief Financial Officer [email protected] +33 1 76 21 47 68

Media relations LifeSci Advisors Sophie Baumont [email protected] +33 6 27 74 74 49

Investor relation LifeSci Advisors Chris Maggos [email protected] +41 79 367 62 54

Pixium Vision is creating a world of bionic vision for those who have lost their sight, enabling them to regain visual perception and greater autonomy. Pixium Vision's bionic vision systems are associated with a surgical intervention and a rehabilitation period. Prima System sub-retinal miniature photovoltaic wireless implant is in clinical testing for patients who have lost their sight due to outer retinal degeneration, initially for atrophic dry age-related macular degeneration (dry AMD). Pixium Vision collaborates closely with academic and research partners, including some of the most prestigious vision research institutions in the world, such as: Stanford University in California, Institut de la Vision in Paris, Moorfields Eye Hospital in London, Institute of Ocular Microsurgery (IMO) in Barcelona, University hospital in Bonn, and UPMC in Pittsburgh, PA. The company is EN ISO 13485 certified and qualifies as "Entreprise Innovante" by Bpifrance.

For more information : http://www.pixium-vision.com/fr Follow us on @PixiumVision; www.facebook.com/pixiumvision www.linkedin.com/company/pixium-vision

Pixium Vision is listed on Euronext Paris (Compartment C). Pixium Vision shares are eligible for the French tax incentivized PEA-PME and FCPI investment vehicles.

Pixium Vision is included in the Euronext CAC All Shares index

Euronext ticker: PIX - ISIN: FR0011950641 – Reuters: PIX.PA – Bloomberg:PIX:FP

Talk to a Data Expert

Have a question? We'll get back to you promptly.